Stock Screener App

Gratuito -

Installare

4.01

0.75% 0.03

Larimar Therapeutics Inc (LRMR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	18.16% 16.73	14.16	10.34	9.62	7.637
Operating Income/Loss	18.16% -16.73	-14.16	-10.34	-9.62	-7.637
Nonoperating Income/Loss	77.93% 2.08	1.169	1.275	1.254	1.111
Income/Loss From Continuing Operations Before Tax	12.78% -14.65	-12.99	-9.064	-8.366	-6.526
Income/Loss From Continuing Operations After Tax	12.78% -14.65	-12.99	-9.064	-8.366	-6.526
Net Income/Loss	12.78% -14.65	-12.99	-9.064	-8.366	-6.526
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	3.41M% 53.55	0.00157	43.90	43.90	43.90
Diluted Average Shares	3.41M% 53.55	0.00157	43.90	43.90	43.90
Basic Earnings Per Share	6.90% -0.27	-0.29	-0.21	-0.19	-0.15
Diluted Earnings Per Share	6.90% -0.27	-0.29	-0.21	-0.19	-0.15
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters